Skip to main content

Select Drug Profiles

Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker

Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations

Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation

Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma

Zanidatamab Shows Promising Activity in Patients with HER2-Overexpressing Gastric Cancers

Wayne Kuznar

Prostate Cancer

¹⁷⁷Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Prostate Cancer

Phoebe Starr

Lung Cancer, Infectious Diseases, Oncology

Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care

Walter Alexander

Walter Alexander

Lung Cancer, Oncology

EGFR Most Common Mutation in Women with Lung Cancer and No Smoking History

Walter Alexander

Walter Alexander

Breast Cancer, Oncology

Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases

Phoebe Starr

Breast Cancer, Oncology

First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer

Phoebe Starr

Page 23 of 244
Results 221 - 230 of 2438